← Evidence map

ArticleEULAR rheumatology open2026

Efficacy and safety of venanprubart, a BTLA agonist antibody, in patients with active systemic lupus erythematosus.

Indrajit Ghosh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42540177